15 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 15 of 15 clinical reviews.
AndroGel can cause gynecomastia through aromatization of testosterone to estradiol. Learn the mechanism, signs that need urgent care, evidence-based management steps, and exactly when to call your prescriber.
A complete clinical guide to grading, explaining, and managing gynecomastia caused by AndroGel testosterone gel, including the Simon, McKinney grading scale, aromatization mechanism, FAERS data, and step-by-step treatment protocols.
AndroGel raises estradiol through aromatization, causing gynecomastia in a measurable share of users. Learn why it happens, how to manage it, and which testosterone delivery formats carry lower gynecomastia risk.
Why AndroGel (testosterone topical) causes gynecomastia, when breast tissue growth becomes permanent, and evidence-based strategies for management including aromatase inhibitors and surgery.
Evidence-based guide to supplements that may help manage gynecomastia caused by AndroGel (testosterone topical), including zinc, DIM, calcium D-glucarate, and grape seed extract.
Evidence-based dietary strategies to reduce gynecomastia risk while on AndroGel (testosterone topical), including anti-aromatase foods, nutrients, and what to avoid.
What diet and exercise can and cannot do for breast enlargement during AndroGel treatment, plus evidence-based evaluation and treatment options.
How common is gynecomastia on AndroGel, how severe does it get, who is most at risk, and what does resolution actually look like? Evidence-anchored answers from TRT trial data and endocrine management literature.
A clinically specific, week-by-week breakdown of when gynecomastia starts, peaks, and resolves on AndroGel testosterone therapy, with trial data and actionable management at each phase.
A clinician-grade, step-by-step protocol for assessing and managing gynecomastia in patients using AndroGel (testosterone topical), covering aromatization mechanics, grading, first-line interventions, escalation criteria, and discontinuation thresholds.
A clinical deep-dive on OTC and prescription options for managing gynecomastia caused by AndroGel testosterone therapy, including dose ranges, drug interactions, and when to escalate care.
A clinical deep-dive on how slowing titration, pausing, stepping down, and microdosing AndroGel can resolve gynecomastia caused by excess aromatization. Real protocols, when each works, and when to escalate.
A clinical threshold guide for patients and prescribers: when gynecomastia from AndroGel warrants dose adjustment, medical intervention, or outright discontinuation, with criteria for switching to alternative TRT formulations.
A clinical-grade explanation of how AndroGel's testosterone aromatizes into estradiol, why breast tissue responds, and what patients and prescribers can do about it right now.
AndroGel (testosterone topical) can cause gynecomastia through aromatization, the enzymatic conversion of testosterone to estradiol. Learn the biology, risk factors, and clinical management.